Audiovisual Stimulation for Hemianopia from Brain Tumors
(HHREHAB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new program called Re:Vision, which uses virtual reality with audio and visual exercises to assist people with hemianopia (loss of vision in half of the visual field) due to brain tumors. The goal is to determine if this 8-week home-based program can improve vision and quality of life for participants. The trial includes two groups: one starts with the program, and the other begins without it, then both switch. Individuals who have had hemianopia for over 18 months and a history of brain tumors might be suitable candidates, especially if they have home Wi-Fi access.
As an unphased trial, this study provides a unique opportunity to explore innovative treatments that could enhance daily living.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that participants should not consume recreational or medicinal psychoactive drugs.
What prior data suggests that this audiovisual stimulation is safe for individuals with hemianopia?
Research has shown that the Re:Vision program, which uses virtual reality to enhance vision, is generally safe for users. In earlier studies, patients used a virtual reality system at home to work on their vision. These studies found the program to be both practical and safe. Participants did not report any major negative side effects during use. This suggests that the treatment is well-tolerated and could be a safe option for people with vision problems due to brain tumors.12345
Why are researchers excited about this trial?
Researchers are excited about Re:Vision for hemianopia caused by brain tumors because it offers a non-invasive approach that uses audiovisual stimulation to potentially restore vision. Unlike traditional therapies that often rely on medication or surgery, Re:Vision targets visual processing pathways in the brain directly. This innovative method could provide a safer and more comfortable alternative for patients, with the potential for fewer side effects and the ability to be used at home.
What evidence suggests that this audiovisual stimulation is effective for hemianopia?
Research has shown that the Re:Vision program, which participants in this trial may receive, may help children who have lost half of their vision due to brain tumors. Early results from young patients suggest that their vision and perception can improve after a 6-week program. Specifically, one study found a strong positive connection between the 3D-MOT-IVR treatment and better vision, indicating the program's effectiveness. The Re:Vision program can be done at home, making it accessible for families who don't live near specialized therapy centers. This accessibility could greatly enhance the quality of life for children with hemianopia.16789
Who Is on the Research Team?
Eric Bouffet, MD
Principal Investigator
Hospital of Sick Children
Michael Reber, MD
Principal Investigator
University Health Network, Toronto
Are You a Good Fit for This Trial?
This trial is for individuals aged 10-40 who have hemianopia due to a pediatric brain tumor. Participants will engage in an at-home visual rehabilitation program using virtual reality, and must be able to perform the exercises independently with remote supervision.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-week audiovisual stimulation program using immersive virtual reality at home
Observation
Participants are observed without intervention to assess the sustainability of the treatment effects
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Re:Vision
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
The Hospital for Sick Children
Collaborator
Alberta Children's Hospital
Collaborator
British Columbia Children's Hospital
Collaborator
St. Justine's Hospital
Collaborator